Biomarkers of Crohn's disease to support the development of new therapeutic interventions

AC Porter, J Aubrecht, C Birch, J Braun… - Inflammatory Bowel …, 2020 - academic.oup.com
Background Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …
被引用次数：15 相关文章

Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions

AC Porter, J Aubrecht, C Birch, J Braun… - Inflammatory Bowel …, 2020 - hero.epa.gov
BACKGROUND: Currently, 2 coprimary end points are used by health authorities to
determine the effectiveness of therapeutic interventions in patients with Crohn's disease …

Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions.

AC Porter, J Aubrecht, C Birch, J Braun… - Inflammatory Bowel …, 2020 - go.gale.com
Background: Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …
[HTML] nih.gov

[HTML][HTML] Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions

AC Porter, J Aubrecht, C Birch, J Braun… - Inflammatory Bowel …, 2020 - ncbi.nlm.nih.gov
Background Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …

Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions.

AC Porter, J Aubrecht, C Birch, J Braun… - Inflammatory Bowel …, 2020 - europepmc.org
Background Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …

Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions

AC Porter, J Aubrecht, C Birch, J Braun… - Inflammatory Bowel …, 2020 - academic.oup.com
Background Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …

Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions

AC Porter, J Aubrecht, C Birch… - Inflammatory …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …